HK Stock MarketDetailed Quotes

00460 SIHUAN PHARM

Watchlist
  • 0.530
  • -0.040-7.02%
Market Closed Mar 28 16:08 CST
4.94BMarket Cap-88333P/E (TTM)

SIHUAN PHARM Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
-14.70%1.86B
-27.90%1.06B
-28.21%2.18B
-23.23%1.46B
23.30%3.04B
80.86%1.91B
-14.39%2.46B
-36.38%1.05B
-1.34%2.88B
29.67%1.66B
Operating income
-14.70%1.86B
-27.90%1.06B
-28.21%2.18B
-23.23%1.46B
23.30%3.04B
80.86%1.91B
-14.39%2.46B
-36.38%1.05B
-1.34%2.88B
29.67%1.66B
Cost of sales
18.56%-564.9M
33.12%-307.97M
-14.10%-693.61M
-4.64%-460.51M
-10.57%-607.9M
-63.92%-440.1M
6.66%-549.78M
8.08%-268.48M
-9.41%-588.99M
-15.65%-292.09M
Operating expenses
18.56%-564.9M
33.12%-307.97M
-14.10%-693.61M
-4.64%-460.51M
-10.57%-607.9M
-63.92%-440.1M
6.66%-549.78M
8.08%-268.48M
-9.41%-588.99M
-15.65%-292.09M
Gross profit
-12.90%1.3B
-25.50%747.73M
-38.79%1.49B
-31.59%1B
26.95%2.43B
86.64%1.47B
-16.38%1.91B
-42.44%786.06M
-3.77%2.29B
33.13%1.37B
Selling expenses
6.13%-442.26M
7.47%-212.49M
12.22%-471.14M
11.99%-229.64M
-45.54%-536.74M
-91.13%-260.92M
-50.29%-368.79M
-15.76%-136.52M
9.49%-245.38M
-16.80%-117.93M
Administrative expenses
15.07%-468.96M
33.76%-212.17M
6.76%-552.19M
-14.95%-320.31M
-20.91%-592.22M
-31.35%-278.66M
-3.86%-489.78M
4.57%-212.16M
-19.05%-471.57M
-23.61%-222.33M
Research and development expenses
38.32%-577.66M
35.70%-294.04M
-7.89%-936.58M
-37.08%-457.27M
-19.05%-868.07M
-10.87%-333.57M
-21.74%-729.16M
-28.76%-300.85M
-24.70%-598.95M
-29.85%-233.65M
Impairment and provision
----
----
-1,215.43%-1.73B
---98.1M
---131.3M
----
----
----
---3.97B
---2.84B
-Impairment of property, machinery and equipment
----
----
----
---98.1M
----
----
----
----
----
----
-Goodwill impairment
----
----
----
----
----
----
----
----
---3.97B
---2.84B
-Other impairment is provision
----
----
-1,215.43%-1.73B
----
---131.3M
----
----
----
----
----
Special items of operating profit
-3.74%354.93M
-61.58%117.12M
-21.51%368.73M
4.39%304.8M
2.04%469.78M
63.49%291.99M
-22.21%460.41M
-49.95%178.6M
-25.50%591.85M
-5.97%356.85M
Operating profit
108.83%161.7M
-28.06%146.16M
-337.16%-1.83B
-77.07%203.18M
-1.93%771.95M
181.14%885.96M
132.71%787.13M
118.59%315.14M
-218.77%-2.41B
-279.51%-1.7B
Financing cost
-27.54%-269.34M
-34.35%-133.54M
-79.95%-211.18M
-529.99%-99.4M
-1,328.15%-117.35M
-894.83%-15.78M
-74.31%-8.22M
32.85%-1.59M
22.21%-4.71M
-15.84%-2.36M
Special items of earning before tax
33.70%-53.62M
4.32%-45.67M
49.00%-80.88M
5.85%-47.73M
-1,113.88%-158.58M
-343.60%-50.7M
-8.72%-13.06M
-60.23%-11.43M
-55.69%-12.02M
66.68%-7.13M
Earning before tax
92.40%-161.26M
-158.98%-33.05M
-527.97%-2.12B
-93.16%56.04M
-35.23%496.01M
171.24%819.48M
131.61%765.84M
117.72%302.12M
-220.42%-2.42B
-285.11%-1.7B
Tax
51.00%-96.43M
43.47%-85.89M
22.25%-196.79M
32.55%-151.94M
-15.56%-253.12M
-68.83%-225.27M
24.57%-219.04M
43.75%-133.43M
12.75%-290.39M
-75.95%-237.22M
After-tax profit from continuing operations
88.89%-257.69M
-24.02%-118.94M
-1,054.97%-2.32B
-116.14%-95.9M
-55.58%242.89M
252.25%594.22M
120.15%546.8M
108.69%168.69M
-261.57%-2.71B
-347.02%-1.94B
After-tax profit from non-continuing business
----
----
458.51%36.3M
----
71.01%-10.12M
----
20.59%-34.92M
-11.19%-24.44M
---43.97M
---21.98M
Earning after tax
88.71%-257.69M
-24.02%-118.94M
-1,080.92%-2.28B
-116.14%-95.9M
-54.53%232.77M
311.92%594.22M
118.56%511.89M
107.34%144.26M
-264.19%-2.76B
-349.81%-1.96B
Minority profit
44.71%-203.67M
49.15%-69.3M
-100.48%-368.36M
-692.03%-136.28M
-577.18%-183.74M
-200.12%-17.21M
1,067.71%38.51M
-110.26%-5.73M
-106.70%-3.98M
171.67%55.85M
Profit attributable to shareholders
97.18%-54.02M
-222.95%-49.64M
-559.75%-1.91B
-93.40%40.38M
-12.01%416.51M
307.64%611.42M
117.19%473.38M
107.43%149.99M
-269.96%-2.75B
-363.81%-2.02B
Basic earnings per share
97.17%-0.0058
-223.26%-0.0053
-564.25%-0.2052
-93.34%0.0043
-11.60%0.0442
308.86%0.0646
117.18%0.05
107.41%0.0158
-270.18%-0.291
-363.99%-0.2133
Diluted earnings per share
97.17%-0.0058
-223.26%-0.0053
-567.43%-0.2052
-93.30%0.0043
-12.20%0.0439
306.33%0.0642
117.18%0.05
107.41%0.0158
-270.18%-0.291
-363.99%-0.2133
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover -14.70%1.86B-27.90%1.06B-28.21%2.18B-23.23%1.46B23.30%3.04B80.86%1.91B-14.39%2.46B-36.38%1.05B-1.34%2.88B29.67%1.66B
Operating income -14.70%1.86B-27.90%1.06B-28.21%2.18B-23.23%1.46B23.30%3.04B80.86%1.91B-14.39%2.46B-36.38%1.05B-1.34%2.88B29.67%1.66B
Cost of sales 18.56%-564.9M33.12%-307.97M-14.10%-693.61M-4.64%-460.51M-10.57%-607.9M-63.92%-440.1M6.66%-549.78M8.08%-268.48M-9.41%-588.99M-15.65%-292.09M
Operating expenses 18.56%-564.9M33.12%-307.97M-14.10%-693.61M-4.64%-460.51M-10.57%-607.9M-63.92%-440.1M6.66%-549.78M8.08%-268.48M-9.41%-588.99M-15.65%-292.09M
Gross profit -12.90%1.3B-25.50%747.73M-38.79%1.49B-31.59%1B26.95%2.43B86.64%1.47B-16.38%1.91B-42.44%786.06M-3.77%2.29B33.13%1.37B
Selling expenses 6.13%-442.26M7.47%-212.49M12.22%-471.14M11.99%-229.64M-45.54%-536.74M-91.13%-260.92M-50.29%-368.79M-15.76%-136.52M9.49%-245.38M-16.80%-117.93M
Administrative expenses 15.07%-468.96M33.76%-212.17M6.76%-552.19M-14.95%-320.31M-20.91%-592.22M-31.35%-278.66M-3.86%-489.78M4.57%-212.16M-19.05%-471.57M-23.61%-222.33M
Research and development expenses 38.32%-577.66M35.70%-294.04M-7.89%-936.58M-37.08%-457.27M-19.05%-868.07M-10.87%-333.57M-21.74%-729.16M-28.76%-300.85M-24.70%-598.95M-29.85%-233.65M
Impairment and provision ---------1,215.43%-1.73B---98.1M---131.3M---------------3.97B---2.84B
-Impairment of property, machinery and equipment ---------------98.1M------------------------
-Goodwill impairment -----------------------------------3.97B---2.84B
-Other impairment is provision ---------1,215.43%-1.73B-------131.3M--------------------
Special items of operating profit -3.74%354.93M-61.58%117.12M-21.51%368.73M4.39%304.8M2.04%469.78M63.49%291.99M-22.21%460.41M-49.95%178.6M-25.50%591.85M-5.97%356.85M
Operating profit 108.83%161.7M-28.06%146.16M-337.16%-1.83B-77.07%203.18M-1.93%771.95M181.14%885.96M132.71%787.13M118.59%315.14M-218.77%-2.41B-279.51%-1.7B
Financing cost -27.54%-269.34M-34.35%-133.54M-79.95%-211.18M-529.99%-99.4M-1,328.15%-117.35M-894.83%-15.78M-74.31%-8.22M32.85%-1.59M22.21%-4.71M-15.84%-2.36M
Special items of earning before tax 33.70%-53.62M4.32%-45.67M49.00%-80.88M5.85%-47.73M-1,113.88%-158.58M-343.60%-50.7M-8.72%-13.06M-60.23%-11.43M-55.69%-12.02M66.68%-7.13M
Earning before tax 92.40%-161.26M-158.98%-33.05M-527.97%-2.12B-93.16%56.04M-35.23%496.01M171.24%819.48M131.61%765.84M117.72%302.12M-220.42%-2.42B-285.11%-1.7B
Tax 51.00%-96.43M43.47%-85.89M22.25%-196.79M32.55%-151.94M-15.56%-253.12M-68.83%-225.27M24.57%-219.04M43.75%-133.43M12.75%-290.39M-75.95%-237.22M
After-tax profit from continuing operations 88.89%-257.69M-24.02%-118.94M-1,054.97%-2.32B-116.14%-95.9M-55.58%242.89M252.25%594.22M120.15%546.8M108.69%168.69M-261.57%-2.71B-347.02%-1.94B
After-tax profit from non-continuing business --------458.51%36.3M----71.01%-10.12M----20.59%-34.92M-11.19%-24.44M---43.97M---21.98M
Earning after tax 88.71%-257.69M-24.02%-118.94M-1,080.92%-2.28B-116.14%-95.9M-54.53%232.77M311.92%594.22M118.56%511.89M107.34%144.26M-264.19%-2.76B-349.81%-1.96B
Minority profit 44.71%-203.67M49.15%-69.3M-100.48%-368.36M-692.03%-136.28M-577.18%-183.74M-200.12%-17.21M1,067.71%38.51M-110.26%-5.73M-106.70%-3.98M171.67%55.85M
Profit attributable to shareholders 97.18%-54.02M-222.95%-49.64M-559.75%-1.91B-93.40%40.38M-12.01%416.51M307.64%611.42M117.19%473.38M107.43%149.99M-269.96%-2.75B-363.81%-2.02B
Basic earnings per share 97.17%-0.0058-223.26%-0.0053-564.25%-0.2052-93.34%0.0043-11.60%0.0442308.86%0.0646117.18%0.05107.41%0.0158-270.18%-0.291-363.99%-0.2133
Diluted earnings per share 97.17%-0.0058-223.26%-0.0053-567.43%-0.2052-93.30%0.0043-12.20%0.0439306.33%0.0642117.18%0.05107.41%0.0158-270.18%-0.291-363.99%-0.2133
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg